Conclusion: Collectively, these data suggest that direct action of leptin on b cells is insufficient to restore normal insulin secretion and glucose tolerance in mice without leptin receptor signaling elsewhere.
INTRODUCTION
Obesity is often associated with elevated circulating insulin levels (hyperinsulinemia), glucose intolerance, and reduced insulin sensitivity [1, 2] . The molecular mechanisms underlying the increased insulin secretion and islet hyperplasia that are often concomitant with obesity remain unclear, but the adipose-derived hormone leptin may be a potential link between adipose tissue and b cells. Leptin has an established role in regulating food intake, adipose metabolism, and glucose homeostasis through signaling in the central nervous system (CNS) [3, 4] . In addition, leptin receptors are distributed in several peripheral tissues involved in glucose regulation including the liver, adipose, and pancreas [5, 6] . Within these tissues, the long isoform of the leptin receptor (Leprb) is believed to mediate the glucoregulatory actions of leptin [7] . In vitro studies have demonstrated that Lepr is expressed in murine and human pancreatic b cells, as well as in b cell lines [8e11] .
Previous studies have attempted to assess whether leptin has a direct action on b cell function, but the results are contradictory. While some studies have found that incubation of human or rodent islets with leptin did not alter the expression or secretion of insulin [12e14] , other studies demonstrated reduced insulin expression and secretion from islets treated with leptin [8,12,15e18] . The inhibitory actions of leptin on b cell function are supported by in vivo characterization of glucose homeostasis and circulating insulin levels in mice lacking leptin or its receptor. In leptin deficient mice (ob/ob) and mice with mutated Lepr (db/db), hyperinsulinemia develops prior to increases in body weight, and islet hyperplasia is evident in these mice [19e21] . When ob/ob mice are treated with leptin, there is a reduction of insulin gene expression and secretion and a reduction of circulating insulin levels within hours [22] . Moreover, doses of leptin insufficient to reduce body weight are sufficient to reverse hyperinsulinemia, indicating that the insulin-lowering effects of leptin can occur independent of weight loss [23] . To elucidate the mechanism by which leptin can regulate insulin secretion and expression, previous studies have employed Cre-loxP technology. Disruption of Lepr in b cells was achieved by Covey et al.
using a rat insulin promoter driving Cre expression (RIPCre) [24] . littermates. Interestingly, a similar approach by Morioka and colleagues to disrupt Lepr using a Pdx-1 (pancreatic duodenal homeobox 1) promoter to drive Cre expression resulted in mice with mildly elevated fasting insulin levels but the absence of obesity [25] . [29] . To assess the direct actions of leptin in b cells, we crossed these mice with Ins1Cre mice to selectively restore Lepr in pancreatic b cells, while functional leptin receptors were absent in other tissues. This provided a unique model with which to assess whether the direct actions of leptin in b cells are sufficient to prevent hyperinsulinemia.
METHODS

Experimental animals
Lepr loxTB/loxTB mice (JAX no. 018989, 50% FVB, 50% C57BL/6J, <1% 129) and Ins1Cre mice (JAX no. 026801, C57BL/6J) [29] were obtained from Jackson Laboratory (Bar Harbor, ME, USA [30] . Briefly, mice were euthanized by CO 2 , and 2 ml of Hank's balanced salt solution (HBSS) containing 1000 units/ml of type XI collagenase (SigmaeAldrich, St. Louis, MO) was immediately injected into the pancreatic duct. Pancreata were digested at 37 C for 11 min and then washed with ice cold HBSS containing 1 mM CaCl 2 . Islets where then hand picked into RPMI 1640 (Sigma Aldrich) containing 0.5% BSA, 100 units/ml penicillin and 100 mg/ml streptomycin. Islets were then flash frozen in liquid nitrogen and stored at À80 C.
Gene deletion
Immediately following euthanasia, mice were decapitated and their brains were isolated. Hypothalami was then dissected on ice and flash frozen. To assess gene deletion, genomic DNA (gDNA) was extracted from flash frozen hypothalamic tissue and islets as previously described [31] . Deletion of the transcriptional blockade upstream of exon 17 in the Lepr gene was assessed using Taqman qPCR probes (IDT) (for primer sequences see Table 1 ; for location of primers in Lepr gene, see Figure 1A ). The degree of recombination was determined using the Pfaffl method in which the deltaCT value of the floxed region of Lepr (target gene) was divided by the deltaCT value of a region upstream of the loxP sites (reference gene).
Islet morphology and immunohistochemistry
Pancreata were collected from 12 to 14 week old mice, fixed overnight in 4% PFA, rinsed in 70% ethanol, embedded in paraffin, and processed for sectioning by Wax-It Histology Services (Vancouver, Canada). Three sections separated by 200 mm per mouse were immunostained for insulin (rabbit anti-insulin antibody, Cat# C27C9, 1:1000, Cell Signaling) and glucagon (mouse anti-glucagon antibody, Cat# G2654, 1:1,000; SigmaeAldrich) or Glut-2 (rabbit anti-Glut-2 antibody, Cat# 07-1402, 1:500, Millipore) overnight at 4 C. Slides were then incubated with AlexaFluor-conjugated secondary antibodies (AF488, AF594; Life Technologies, Burlington, Ontario, Canada) for 1 h at room temperature followed by counterstaining with DAPI to identify nuclei. Sections were scanned and quantified as previously described [32] . The insulin and glucagon positive areas are expressed relative to the whole pancreas area and averaged across three pancreas sections per mouse (n ¼ 3e5 per group). Islet sizes were approximated by measuring insulin positive area of each islet in three pancreas sections (separated by 200 mm) per mouse. Islet sizes were then binned into ranges and the histogram analysis function in Microsoft Excel (2016) was used to determine the frequency of islets per size range. Frequency was represented as a percentage of total number of islets assessed per animal. Figure 1 : Lepr was restored in mice with a transcriptional blockade (TB) upstream of exon 17 in Lepr by recombination of loxP sites flanking the TB using Ins1Cre (A). Percent recombination was assessed by measuring the ratio of qPCR product obtained using primers within and outside of the TB region (primers 1 and 2, respectively in A) of gDNA extracted from islets (B) and hypothalamus (C). Mice expressing mT/mG were used to determine the extent of recombination in islets with Ins1Cre. Representative images were collected from pancreata of mT/mG Ins1Cre and mT/mG mice co-stained for insulin (red) and EGFP (green) and DAPI (gray) (D; n ¼ 3e4). Expression of GFP indicates Cre-mediated recombination. Scale bar represents 100 mm. Fasted insulin levels were measured at 5 weeks of age (E), along with fasting glucose levels (F) and body weight (G) between 5 and 12 weeks of age in male mT/mG Ins1Cre and mT/mG mice. Blood glucose was measured following an i.p. injection of insulin (0.75 U/kg body weight) to assess insulin sensitivity in 6-week old mice (H). Plasma insulin levels were measured in 8-week old mice following a gavage of 40% glucose (1.5 g/kg body weight) to assess glucose tolerance and glucose stimulated insulin secretion (I, J). Values are presented as individual data points in B, C, E, and J with a line indicating the median and the shaded area spanning the range of values. A student's t-test with P < 0.05 was used to determine statistical significance. Values in F-I are presented as mean AE SEM and a repeated one-way ANOVA with Tukey post-hoc test was used to assess statistical significance (n ¼ 4e6/group). Figure 1A . Primer set 1 was used to amplify sequence within the transcriptional blockade region of Lepr while Primer set 2 was used to amplify exon 17 within Lepr. 
RESULTS
Validation of Lepr restoration in b cells
To assess recombination of the Lepr loxTB/loxTB site in the presence of Ins1Cre, islets were isolated from 11 to 13 week old Lepr loxTB/loxTB and Lepr loxTB/loxTB Ins1Cre mice, and gDNA was extracted for analysis by qPCR. A w75% rate of recombination of Lepr was observed in islets of Lepr loxTB/loxTB Ins1Cre mice, while the recombination of Lepr in islets of Lepr loxTB/loxTB mice was less than 10% ( Figure 1B) . Recombination of Lepr in islets was compared to recombination of Lepr in the hypothalamus to assess the tissue specificity of Ins1Cre. The percent of recombination in the hypothalamus was minimal and was comparable between Lepr loxTB/loxTB Ins1Cre and Lepr loxTB/loxTB mice ( Figure 1C ). Next, we crossed Ins1Cre mice with mT/mG reporter mice to determine whether Ins1Cre produced recombination in b cells. These double fluorescent reporter mice express membrane-targeted dimer Tomato prior to Cre-mediated excision and membrane-targeted enhanced green fluorescent protein (EGFP) after excision [33] . Immunostaining of EGFP in fixed pancreas from mT/mG Ins1Cre and mT/ mG control mice revealed EGFP expression co-localized in b cells of mT/mG Ins1Cre mice ( Figure 1D ), indicating that Cre-induced recombination occurred in b cells. To determine whether replacing 1 insulin allele with Cre influenced glucose homeostasis and metabolism, we also assessed body weight, fasting glucose, glucose tolerance, and insulin sensitivity in male mT/mG Ins1Cre mice between the ages of 4e12 weeks. Fasting insulin, blood glucose, and body weight levels were similar between mT/mG Ins1Cre mice and mT/mG mice (Figure 1EeG) . Similarly, no differences in insulin sensitivity, glucose tolerance, or glucose stimulated insulin secretion were observed (Figure 1HeJ) . Therefore, our characterization of the Ins1Cre line confirms and extends previously published data [34] and demonstrates that knock-in of Cre into one allele of Ins1 does not appear to significantly affect glucose homeostasis.
Lepr in b cells is not sufficient to regulate islet morphology or b cell area
It has been previously reported that whole body mutation of Lepr [21] or knockout of Lepr in the pancreas of chow-fed mice [25] Figure 4A , D). Fifteen minutes after glucose gavage, blood glucose levels of male and female Lepr wt/wt and Lepr wt/wt Ins1Cre mice peaked between 15 and 18 mM. In contrast, glucose levels of Lepr loxTB/loxTB and Lepr loxTB/loxTB Ins1Cre mice peaked above the limit of detection (33.3 mM, represented as a dashed line on the graph), indicating they were severely glucose intolerant. Analysis of area under the curve (AUC) revealed that Lepr loxTB/loxTB and Lepr loxTB/loxTB Ins1Cre mice were significantly glucose intolerant compared to control littermate mice ( Figure 4B, E) . In response to glucose gavage, male and female Lepr wt/wt and Lepr wt/wt Ins1Cre mice had fasting plasma insulin levels between 0.1 and 0.7 ng/ml, and insulin levels peaked at 0.3e 1.1 ng/ml at the 15-minute time point (Figure 4C, F) . In contrast, Lepr loxTB/loxTB and Lepr loxTB/loxTB Ins1Cre mice had fasting insulin levels that were w10-fold higher than Lepr wt/wt mice and peak glucose stimulated insulin secretion levels that were between 15 and 30-fold higher than Lepr wt/wt mice. Fasting as well as glucose stimulated plasma insulin levels were comparable between Lepr loxTB/loxTB and Lepr loxTB/loxTB Ins1Cre mice. Despite similar glucose levels in response to oral glucose gavage, basal plasma insulin levels and glucose stimulated insulin secretion was different between male and female mice. Female Lepr loxTB/loxTB and Lepr loxTB/loxTB Ins1Cre mice had lower basal insulin levels compared to males ( Figures 3C, D and 4C, F) , and insulin secretion in response to glucose was much higher in female Lepr loxTB/ loxTB as compared to male mice of the same genotype ( Figure 4C, F) .
DISCUSSION
To examine the effects of restoring Lepr in b cells on insulin secretion and morphology, we crossed mice expressing Cre knocked into the Ins1 gene with Lepr loxTB/loxTB mice, which have a transcriptional blockade inserted between exon 16 and exon 17 of Lepr, resulting in impaired leptin signaling. Disruption of the leptin receptor signaling domain in Lepr loxTB/loxTB mice results in a phenotype similar to db/db mice, characterized by obesity, hyperinsulinemia, hyperglycemia, insulin resistance, and islet hyperplasia [35, 36] . Cre-mediated removal of the transcriptional blockade and restoration of Lepr can be achieved in Lepr loxTB/loxTB mice in a cell-type selective manner, enabling the assessment of the physiological impact of Lepr in specific tissues. Restoration of Lepr in b cells of Lepr loxTB/loxTB Ins1Cre mice did not alter the development of hyperinsulinemia, hyperglycemia, glucose intolerance, and obesity, suggesting that leptin signaling in b cells does not suppress insulin secretion. Moreover, islet hyperplasia was still present in Lepr loxTB/loxTB Ins1Cre mice, similarly to what is reported in db/db mice [35] . However, as we did not follow the mice for an extended period of time, our studies cannot rule out the possibility that the restoration of Lepr in b cells may have prevented age related b cell failure that eventually results in overt severe diabetes, like in db/db mice [37, 38] .
A distinct difference between the present study and previous studies in which Lepr was selectively deleted [24, 25, 28] partial correction of body weight [39] . These authors concluded that Lepr in the CNS is able to rescue the diabetic and obese phenotype of and rodent islets and cell lines [9,40e43] ; however, in another study, non-detectable levels of Lepr were reported in b cells from dispersed islets using RT-qPCR [28] . More recently, studies using single-cell RNA-seq to determine the transcriptome profiles of human and murine islets revealed that the expression of Lepr was higher in d cells than b cells [44, 45] . Though insulin secretion and expression was reduced in isolated murine and human islets treated with leptin [8, 10, 12] , this effect may have been a result of leptin acting on d cells.
Collectively, this suggests that despite restoration of Lepr in Lepr loxTB/ loxTB Ins1Cre mice, the relatively low levels of Lepr in b cells may not be sufficient to provoke improvements in b cell function in the absence of leptin receptor signaling in other pancreatic islet populations. The presence of hyperinsulinemia and islet hyperplasia despite restoration of Lepr in b cells of Lepr loxTB/loxTB mice may be due to hyperleptinemia that was present in Lepr loxTB/loxTB Ins1Cre mice. Plasma leptin levels were w150-fold higher in Lepr loxTB/loxTB Ins1Cre mice compared to control mice. Hyperleptinemia has been previously observed in Lepr loxTB/loxTB [29] , and in mice with disruption of Lepr in peripheral tissues [46] . This increase of plasma leptin levels was attributed to the disruption of Lepr in white adipose tissue (WAT), which led to inactivation of a negative feedback loop regulating leptin synthesis in WAT [46] . Indeed the presence of hyperleptinemia can cause leptin resistance [47] . Thus, despite restoration of Lepr in b , and Lepr loxTB/loxTB Ins1Cre mice between 7 and 12 weeks of age were fasted for 6 h to assess glucose tolerance by gavage of 40% glucose at a dose of 1.5 g glucose/kg body weight. Blood glucose was measured every 15 min and area under the curve was analyzed (B, E). Blood collected at 0, 15 and 60 min of the glucose tolerance test was used to measure plasma insulin levels (C, F). Values are presented as mean AE SEM in panels A, C, D, and F while values in B and E are presented individually with a line indicating the median. A one-way ANOVA with Tukey post hoc analysis was used to assess statistical significance (n ¼ 3e7 per group).
